F G De Rosa
Overview
Explore the profile of F G De Rosa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
669
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maffezzoli P, Kestler M, Burillo A, Corcione S, De Rosa F, Munoz P, et al.
Rev Esp Quimioter
. 2024 Nov;
38(1):8-20.
PMID: 39556409
Time to positivity (TTP) refers to the duration required for a microbiological culture test to indicate a positive result, marking the onset of detectable bacterial or fungal growth in the...
2.
Vicentini C, Russotto A, Bussolino R, Castagnotto M, Gastaldo C, Bresciano L, et al.
J Hosp Infect
. 2024 Apr;
149:14-21.
PMID: 38677480
Background: It is unknown whether COVID-19 patients are at higher risk due to demographic and clinical characteristics associated with higher COVID-19 infection risk and severity of infection, or due to...
3.
Montrucchio G, Lupia T, Lombardo D, Stroffolini G, Corcione S, De Rosa F, et al.
Ann Intensive Care
. 2021 Sep;
11(1):136.
PMID: 34524562
Invasive pulmonary aspergillosis (IPA) has always been a challenging diagnosis and risk factors an important guide to investigate specific population, especially in Intensive Care Unit. Traditionally recognized risk factors for...
4.
Montrucchio G, Corcione S, Sales G, Curtoni A, De Rosa F, Brazzi L
J Glob Antimicrob Resist
. 2020 Nov;
23:398-400.
PMID: 33242674
Here we report on seven intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS) who developed positive rectal swabs and invasive infections due to...
5.
Bassetti M, Giacobbe D, Aliberti S, Barisione E, Centanni S, De Rosa F, et al.
Clin Microbiol Infect
. 2020 May;
26(7):880-894.
PMID: 32360444
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19), which has rapidly become epidemic in Italy and other European countries. The disease...
6.
Corcione S, Sidoti F, Costa C, Mornese Pinna S, Bonetto C, Urbino R, et al.
New Microbes New Infect
. 2019 Apr;
29:100529.
PMID: 30988955
We herein report the case of a young immunocompetent adult patient with a rapidly fatal haemophagocytic lymphohistiocytosis syndrome related to human herpesvirus 1 (HHV-1) infection, with herpetic hepatitis and persistent...
7.
Lavezzo B, Patrono D, Tandoi F, Martini S, Fop F, Ballerini V, et al.
Transpl Infect Dis
. 2018 Feb;
20(2):e12859.
PMID: 29427394
Background: Invasive fungal infection (IFI) is a severe complication of liver transplantation burdened by high mortality. Guidelines recommend targeted rather than universal antifungal prophylaxis based on tiers of risk. Methods:...
8.
Bassetti M, Giacobbe D, Giamarellou H, Viscoli C, Daikos G, Dimopoulos G, et al.
Clin Microbiol Infect
. 2017 Sep;
24(2):133-144.
PMID: 28893689
Background: Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-KP) has become one of the most important contemporary pathogens, especially in endemic areas. Aims: To provide practical suggestion for physicians dealing with...
9.
Giacobbe D, Del Bono V, Bruzzi P, Corcione S, Giannella M, Marchese A, et al.
Eur J Clin Microbiol Infect Dis
. 2016 Dec;
36(4):663-669.
PMID: 27909821
Introduction: the purpose of this retrospective multicenter study was to assess whether the risk of developing bloodstream infections (BSI) due to carbapenem-resistant Klebsiella pneumoniae (CRKP) in colonized patients is influenced...
10.
Russo A, Concia E, Cristini F, De Rosa F, Esposito S, Menichetti F, et al.
Clin Microbiol Infect
. 2016 Apr;
22 Suppl 2:S27-36.
PMID: 27125562
In 2013 the US Food and Drug Administration (FDA) issued recommendations and guidance on developing drugs for treatment of skin infection using a new definition of acute bacterial skin and...